Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

BACKGROUND: Controlled trials have found therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) infusion therapy to be equally efficacious in treating Guillain-Barré syndrome (GBS). Due to increases in the price of IVIg compared to human serum albumin (HSA), used as a replacement fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Winters, Jeffrey L, Brown, David, Hazard, Elisabeth, Chainani, Ashok, Andrzejewski, Chester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121582/
https://www.ncbi.nlm.nih.gov/pubmed/21575219
http://dx.doi.org/10.1186/1472-6963-11-101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121582/
https://www.ncbi.nlm.nih.gov/pubmed/21575219
http://dx.doi.org/10.1186/1472-6963-11-101

Ejemplares similares